Anti-CD22 Antibody Targeting of pH-responsive Micelles Enhances Small Interfering RNA Delivery and Gene Silencing in Lymphoma Cells

The application of small interfering RNA (siRNA) for cancer treatment is a promising strategy currently being explored in early phase clinical trials. However, efficient systemic delivery limits clinical implementation. We developed and tested a novel delivery system comprised of (i) an internalizin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Palanca-Wessels, Maria C, Convertine, Anthony J, Cutler-Strom, Richelle, Booth, Garrett C, Lee, Fan, Berguig, Geoffrey Y, Stayton, Patrick S, Press, Oliver W
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2011
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3149160/
https://ncbi.nlm.nih.gov/pubmed/21629223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.104
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi